Safety evaluation of desloratadine in allergic rhinitis

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.3, 2013-05, pp. : 445-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Desloratadine - a new option in allergic rhinitis

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Desloratadine in Subjects with Seasonal Allergic Rhinitis or Chronic Urticaria: Results of Four Postmarketing Surveillance Studies

By Bachert Claus

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 109-122

Adis International

Access to resources Recommend Favorite

The Safety and Efficacy of Desloratadine for the Management of Allergic Disease

By Berger William E.

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1101-1118

Adis International

Access to resources Recommend Favorite

Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders

By DuBuske Lawrence M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2511-2523

Informa Healthcare

Access to resources Recommend Favorite

Treating Allergic Rhinitis in Pregnancy: Safety Considerations

By Mazzotta P. Loebstein R. Koren G.

Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. : 361-375

Adis International

Access to resources Recommend Favorite